Gilead Strikes $2.48 Billion Deal with Nurix to Focus on Protein Degradation Jun 19, 2019 Life Science
BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor Jun 18, 2019 Life Science
CASI Acquires Global Rights To CD19 T-Cell Therapy; Will Make $11.6 Million Investment Jun 18, 2019 Life Science
Hansoh Completes $1 Billion Hong Kong IPO; Rises 37% in First Trading Session Jun 14, 2019 Life Science
MORE Health Announces Strategic Collaboration with Memorial Sloan Kettering Cancer Center Jun 13, 2019 Life Science
Proton Clinical Research Center of the Shandong Cancer Hospital First APAC Member of FlashForward Consortium Jun 12, 2019 Life Science
